TCTMD

TCTMD Your source for breaking news, topical videos, and slides covering cardiovascular disease and interv

TCTMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine.

08/12/2026

Known for his honesty and for igniting controversy, Taggart will be remembered for always putting patient interests first.

08/12/2026

Waist-based measurements paint a more comprehensive picture and can reclassify patients’ cardiovascular risk, a large dataset suggests.

While in-hospital mortality after M-TEER doesn't diverge by s*x, new data analysis finds that differences in contemporar...
08/12/2026

While in-hospital mortality after M-TEER doesn't diverge by s*x, new data analysis finds that differences in contemporary practice and device utilization still exist. Dive into the full story for deeper insights!

https://bit.ly/4wzkK48

Women were, however, more likely to experience bleeding and cardiac tamponade and less likely to get an ICD/CRT-D device.

08/12/2026

Kausik Ray talks with host Yael L. Maxwell about how he knew his path early but still made pivots, all the while putting patients' needs first.

08/11/2026

The scientific statement discusses the need for cardiologists to have a broader perspective on improving health in older patients.

The TRI-NOCA study reveals a groundbreaking "actionable process" that's changing lives for ANOCA patients. Read the full...
08/11/2026

The TRI-NOCA study reveals a groundbreaking "actionable process" that's changing lives for ANOCA patients. Read the full story to discover how this innovative approach is delivering improvements in quality of life. https://bit.ly/4q7Elqg

This “actionable process” harnesses invasive coronary functional testing to enable tailored care, a TRI-NOCA investigator says.

08/10/2026

The findings align with the trial’s main analysis, but other studies of revascularization in CLTI have come to the opposite conclusion.

The phase III ZEUS trial produced findings that ASCVD patients susceptible to major adverse cardiovascular events should...
08/10/2026

The phase III ZEUS trial produced findings that ASCVD patients susceptible to major adverse cardiovascular events should know. Read the attached article to learn more.

https://bit.ly/4q5Pg3M

The drug lowered free IL-6 and hs-CRP levels but didn’t affect outcomes, raising doubts about the inflammatory hypothesis.

July's top stories on TCTMD were packed with critical updates! Our most read articles covered the 2026 dyslipidemia guid...
08/09/2026

July's top stories on TCTMD were packed with critical updates! Our most read articles covered the 2026 dyslipidemia guidelines, the universal definition of heart failure, and more. Read here: https://bit.ly/4fMKLI4

New data reveals a link between higher lipoprotein(a) levels and increased VTE risk in both pre- and postmenopausal wome...
08/08/2026

New data reveals a link between higher lipoprotein(a) levels and increased VTE risk in both pre- and postmenopausal women on HRT. Discover what these findings mean for women's health. https://bit.ly/3RVNeXe

The thrombotic risk correlated with the lipoprotein may indeed be context dependent, researchers say.

Address

1700 Broadway
New York, NY
10019

Website

Alerts

Be the first to know and let us send you an email when TCTMD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category